PROCEPT BioRobotics Corp (PRCT): R&D Expense
$71.28M
Year ended 2025-12-31
$78.81M
Trailing 12 months to 2026-06-30
+35.0%
3-year compound annual growth
+34.4%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $71.28M | +14.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $62.30M | +28.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $48.45M | +67.2% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $28.98M | +52.6% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $18.99M | +16.7% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $16.27M | n/a | 2022-03-22, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | 2025-12-31 | $71.28M | +14.4% |
| SkinHealth Systems Inc. (SKIN) | 2025-12-31 | $5.63M | -10.6% |
| Angiodynamics Inc (ANGO) | 2026-05-31 | $29.45M | +12.3% |
| Tactile Systems Technology Inc (TCMD) | 2025-12-31 | $8.48M | -4.0% |
| Lemaitre Vascular Inc (LMAT) | 2025-12-31 | $14.14M | -9.7% |
| Orthopediatrics Corp (KIDS) | 2025-12-31 | $9.10M | -17.5% |
| Accuray Inc (ARAY) | 2026-06-30 | $37.75M | -21.3% |
| Cerus Corp (CERS) | 2025-12-31 | $67.72M | +15.0% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $15.10M | +22.3% |
Compare PRCT, SKIN, ANGO, TCMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗